I recommended a buy rating for Progyny, Inc. (NASDAQ: PGNY ) when I wrote about it on 3rd June this year, as I saw no change to the long-term growth outlook and that anyI consider an investment ideal if it performs its core business in a sector projected to experience structural (organic) growth in excess of GDP growth over the next 5-10 years; profits from sustainable competitive advantages that translate into attractive unit economics; In the hands of competent, ethical, and long-term thinkers; with a fai ...